(1888PressRelease)
February 04, 2008 - Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which outlines the competitive dynamics of 24 different emergent pharma markets. It finds that China has the largest healthcare spend of all emerging Asian economies, totalling $74.2bn in 2003.
Additionally,“Emerging Pharmaceutical Markets-Growth Opportunities, Changing Healthcare Dynamics And Regulatory Trends” which is available at
http://www.piribo.com/publications/country/emerging_pharmaceutical_markets.html finds that the growth of emerging pharmaceutical markets remains impressively buoyant, having attained a 14.7% value increase over the 2005-06 period, a substantially greater rate than those witnessed within the developed markets of the EU and US.
The report highlights that Latin America offers significant sales potential for ACE Inhibitors and analgesics, because of a high frequency of cardiovascular disorders across the region. Hypercholesterolemia, Latin America's most common cardiovascular risk factor, had an estimated prevalence rate of 32% in 2004, and is forecast to rise to 34.6% by 2010.
Authors of the report say that the five main therapeutic areas within emergent markets constituted 66.7% of total sales, or $49.6bn, in 2006, with alimentary,metabolic and anti-infective products leading the market. Systemic antibiotics and antacids continued to dominate growth.
Analysts point out that although emergent markets contain sizeable patient populations, significant barriers to entry continue to exist. For Western players, successful entry depends upon a comprehensive understanding of market dynamics, including differentiated growth prospects, sociopolitical structures and local market environments.
The report analyses 24 countries across Asia, Central and Eastern Europe, and Latin America. The impact of licensing laws and reforms upon market penetration potential within these countries is assessed, and the trends that influence market opportunities are profiled. This report will also provide detailed analyses and forecasts to establish the future direction of emergent markets, and identify the key strategies necessary in securing successful market entry and sustainable growth.
“Emerging Pharmaceutical Markets-Growth Opportunities, Changing Healthcare Dynamics And Regulatory Trends” is available in pdf format from Piribo.
Piribo product ID: RBI154
About Piribo.
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 7,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.
###
